How Diet and Gut Microbiota Influence the Endocannabinoid System
A July 2026 mechanistic review explains the dietary impact on endocannabinoid system by detailing how fatty acids and gut microbiota jointly regulate the endocannabinoidome. This review clarifies the biological mechanisms without clinical treatment…
Medicinal Cannabis and Fibromyalgia: Endocannabinoid Biomarkers Trial
This fibromyalgia endocannabinoid biomarkers trial evaluated whether oral THC:CBD cannabis oil changes blood markers in women with fibromyalgia. The study found no significant changes in plasma PEA, OEA, or SEA levels compared to placebo. These results…
Blog: Can AI-Guided Cannabinoid Care Become Reliable?
AI-guided cannabinoid care may eventually help explain why patients respond so differently to similar products, doses, and diagnoses. This essay examines how longitudinal data, product chemistry, physiology, and clinical outcomes could support better…
Can the Endocannabinoid System Help Explain Bruxism? What a New Neurobiological Model Proposes
A July 2026 Frontiers in Neuroscience paper proposes the endocannabinoid system bruxism neuromodulation hypothesis, suggesting ECS may regulate brain circuits behind bruxism. This is a translational model, not a clinical trial, highlighting a promising…
Medicinal Cannabis and Fibromyalgia: Biomarker Trial Insights
The fibromyalgia endocannabinoid biomarkers trial found no significant changes in peripheral blood markers after oral THC:CBD cannabis oil treatment, despite reported pain relief. This highlights the complexity of monitoring cannabis effects in…
Cannabis Oil and Fibromyalgia: Clinical Benefit Without Blood Biomarker Change
This oral THC CBD fibromyalgia trial tested a 1:1 THC:CBD oil over 16 weeks in women with fibromyalgia. Despite no changes in peripheral blood endocannabinoid biomarkers, clinical benefits were reported. The findings suggest central nervous system…
In the Mix: 15 More Articles — July 07, 2026
Legislators receive medical cannabis update reflecting ongoing policy concerns and clinical relevance in 2026. This update informs clinicians about potential regulatory changes. Understanding these developments is key for evidence-based cannabis medicine.
Endocannabinoid System & Alcohol Use Disorder: Evidence from Preclinical & Human Studies
The endocannabinoid system alcohol use disorder evidence highlights its role in regulating reward, stress, and emotional processing. Preclinical studies show cannabinoid receptor modulators reduce alcohol intake. However, human trials have shown…
Cannabis Reduces Tics in Tourette Syndrome: 306 Patients
Dr. Benjamin Caplan, MD | Board-Certified Family Physician & Cannabis Medicine Specialist | Cannabis Science | June 5, 2026 Clinical Insight A meta-analysis of eight clinical studies and 306 adult patients found that cannabis-based medicines produced…
Scientist explains ‘only two methods’ to stop weed smoker’s horrific ‘scromiting’ side effect
✦ New CED Clinical Relevance #76 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. ResearchTHCSafetyNeurologyMental HealthDosingEndocannabinoid System Why This Matters Cannabinoid Hyperemesis…